North West Skincare Ltd 07302484 false 2024-11-01 2025-10-31 2025-10-31 The principal activity of the company is private dermatologist practice Digita Accounts Production Advanced 6.30.9574.0 true true 07302484 2024-11-01 2025-10-31 07302484 2025-10-31 07302484 bus:OrdinaryShareClass1 bus:CumulativeShares 2025-10-31 07302484 bus:OrdinaryShareClass2 bus:CumulativeShares 2025-10-31 07302484 core:RetainedEarningsAccumulatedLosses 2025-10-31 07302484 core:ShareCapital 2025-10-31 07302484 core:FinancialAssetsDesignatedFairValueThroughProfitOrLoss core:Non-currentFinancialInstruments 2025-10-31 07302484 core:CurrentFinancialInstruments 2025-10-31 07302484 core:CurrentFinancialInstruments core:WithinOneYear 2025-10-31 07302484 core:FurnitureFittingsToolsEquipment 2025-10-31 07302484 bus:SmallEntities 2024-11-01 2025-10-31 07302484 bus:AuditExemptWithAccountantsReport 2024-11-01 2025-10-31 07302484 bus:FullAccounts 2024-11-01 2025-10-31 07302484 bus:SmallCompaniesRegimeForAccounts 2024-11-01 2025-10-31 07302484 bus:RegisteredOffice 2024-11-01 2025-10-31 07302484 bus:Director1 2024-11-01 2025-10-31 07302484 bus:Director2 2024-11-01 2025-10-31 07302484 bus:OrdinaryShareClass1 bus:CumulativeShares 2024-11-01 2025-10-31 07302484 bus:OrdinaryShareClass2 bus:CumulativeShares 2024-11-01 2025-10-31 07302484 bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 07302484 bus:Agent1 2024-11-01 2025-10-31 07302484 core:RetainedEarningsAccumulatedLosses 2024-11-01 2025-10-31 07302484 core:ShareCapital 2024-11-01 2025-10-31 07302484 core:ComputerEquipment 2024-11-01 2025-10-31 07302484 core:FurnitureFittingsToolsEquipment 2024-11-01 2025-10-31 07302484 core:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntity 2024-11-01 2025-10-31 07302484 core:UKTax 2024-11-01 2025-10-31 07302484 1 2024-11-01 2025-10-31 07302484 countries:AllCountries 2024-11-01 2025-10-31 07302484 2024-10-31 07302484 core:RetainedEarningsAccumulatedLosses 2024-10-31 07302484 core:ShareCapital 2024-10-31 07302484 core:FurnitureFittingsToolsEquipment 2024-10-31 07302484 2023-11-01 2024-10-31 07302484 2024-10-31 07302484 bus:OrdinaryShareClass1 bus:CumulativeShares 2024-10-31 07302484 bus:OrdinaryShareClass2 bus:CumulativeShares 2024-10-31 07302484 core:FinancialAssetsDesignatedFairValueThroughProfitOrLoss core:Non-currentFinancialInstruments 2024-10-31 07302484 core:CurrentFinancialInstruments 2024-10-31 07302484 core:CurrentFinancialInstruments core:WithinOneYear 2024-10-31 07302484 core:FurnitureFittingsToolsEquipment 2024-10-31 07302484 bus:OrdinaryShareClass1 bus:CumulativeShares 2023-11-01 2024-10-31 07302484 bus:OrdinaryShareClass2 bus:CumulativeShares 2023-11-01 2024-10-31 07302484 core:RetainedEarningsAccumulatedLosses 2023-11-01 2024-10-31 07302484 core:ShareCapital 2023-11-01 2024-10-31 07302484 core:UKTax 2023-11-01 2024-10-31 07302484 2023-10-31 07302484 core:RetainedEarningsAccumulatedLosses 2023-10-31 07302484 core:ShareCapital 2023-10-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 07302484

North West Skincare Ltd
Annual Report and Unaudited Financial Statements
for the Year Ended 31 October 2025

North West Skincare Ltd

Contents

Company Information | 1
Directors' Report | 2
Accountants' Report | 3
Profit and Loss Account | 4
Statement of Comprehensive Income | 5
Balance Sheet | 6
Statement of Changes in Equity | 7
Notes to the Unaudited Financial Statements | 8 to 13
Detailed Profit and Loss Account | 14 to 16

North West Skincare Ltd

Company Information

Directors | Dr John Thomas Lear Dr. Mary Theresa Atherton

Registered office | 3 Crewe Road Sandbach Cheshire CW11 4NE

North West Skincare Ltd

Directors' Report for the Year Ended 31 October 2025

The directors present their report and the financial statements for the year ended 31 October 2025.

Directors of the company

The directors who held office during the year were as follows:

Dr John Thomas Lear

Dr. Mary Theresa Atherton

Principal activity

The principal activity of the company is private dermatologist practice

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the Board on 10 June 2026 and signed on its behalf by:

......................................... Dr John Thomas Lear Director
......................................... Dr. Mary Theresa Atherton Director

Chartered Certified Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
North West Skincare Ltd
for the Year Ended 31 October 2025

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of North West Skincare Ltd for the year ended 31 October 2025 as set out on pages 4 to 13 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at
http://www.accaglobal.com/gb/en/discover/public-value/rulebook.html.

This report is made solely to the Board of Directors of North West Skincare Ltd, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of North West Skincare Ltd and state those matters that we have agreed to state to the Board of Directors of North West Skincare Ltd, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/gb/en/technical-activities/technical-resources-search/2009/
october/factsheet-163-audit-exempt-companies.html. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than North West Skincare Ltd and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that North West Skincare Ltd has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of North West Skincare Ltd. You consider that North West Skincare Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of North West Skincare Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................
Knight Brown Chartered Certified Accountants
3 Crewe Road
Sandbach
Cheshire
CW11 4NE

10 June 2026

North West Skincare Ltd

Profit and Loss Account for the Year Ended 31 October 2025

| Note | 2025 £ | 2024 £
Turnover |  | 383,198 | 406,331
Gross profit |  | 383,198 | 406,331
Administrative expenses |  | (123,428) | (180,946)
Operating profit |  | 259,770 | 225,385
Other interest receivable and similar income |  | 1,547 | 2,777
Profit before tax | 5 | 261,317 | 228,162
Tax on profit |  | (67,917) | (58,632)
Profit for the financial year |  | 193,400 | 169,530

The above results were derived from continuing operations.

The company has no recognised gains or losses for the year other than the results above.

North West Skincare Ltd

Statement of Comprehensive Income for the Year Ended 31 October 2025

| 2025 £ | 2024 £
Profit for the year | 193,400 | 169,530
Total comprehensive income for the year | 193,400 | 169,530

North West Skincare Ltd

(Registration number: 07302484)
Balance Sheet as at 31 October 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Tangible assets | 6 | 10,739 | 8,839
Other financial assets | 7 | 200,000 | 200,000
|  | 210,739 | 208,839
Current assets |  |  |
Debtors | 8 | 758,521 | 756,933
Cash at bank and in hand |  | 521,253 | 329,868
|  | 1,279,774 | 1,086,801
Creditors: Amounts falling due within one year | 9 | (192,502) | (151,679)
Net current assets |  | 1,087,272 | 935,122
Net assets |  | 1,298,011 | 1,143,961
Capital and reserves |  |  |
Called up share capital | 10 | 200 | 200
Retained earnings |  | 1,297,811 | 1,143,761
Shareholders' funds |  | 1,298,011 | 1,143,961

For the financial year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and FRS 102 ‘The Financial Reporting Standard Applicable in the UK and Republic of Ireland’.

Approved and authorised by the Board on 10 June 2026 and signed on its behalf by:

......................................... Dr John Thomas Lear Director
......................................... Dr. Mary Theresa Atherton Director

North West Skincare Ltd

Statement of Changes in Equity for the Year Ended 31 October 2025

| Share capital £ | Retained earnings £ | Total £
At 1 November 2024 | 200 | 1,143,761 | 1,143,961
Profit for the year | - | 193,400 | 193,400
Dividends | - | (39,350) | (39,350)
At 31 October 2025 | 200 | 1,297,811 | 1,298,011

| Share capital £ | Retained earnings £ | Total £
At 1 November 2023 | 200 | 1,021,725 | 1,021,925
Profit for the year | - | 169,530 | 169,530
Dividends | - | (47,494) | (47,494)
At 31 October 2024 | 200 | 1,143,761 | 1,143,961

North West Skincare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

1 | General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
3 Crewe Road
Sandbach
Cheshire
CW11 4NE
United Kingdom

The principal place of business is:
72, Bridge Lane
Bramhall
Stockport
Cheshire
SK7 3AW
England

These financial statements were authorised for issue by the Board on 10 June 2026.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

North West Skincare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Computer equipment | 33% on cost

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

North West Skincare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.
Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 4 (2024 - 4).

4 | Taxation

Tax charged/(credited) in the profit and loss account

| 2025 £ | 2024 £
Current taxation |  |
UK corporation tax | 67,917 | 58,632

5 | Profit before tax

Arrived at after charging/(crediting)

| 2025 £ | 2024 £
Depreciation expense | 3,725 | 3,695

North West Skincare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

6 | Tangible assets

| Furniture, fittings and equipment £ | Total £
Cost or valuation
At 1 November 2024 | 21,220 | 21,220
Additions | 5,624 | 5,624
At 31 October 2025 | 26,844 | 26,844
Depreciation
At 1 November 2024 | 12,381 | 12,381
Charge for the year | 3,724 | 3,724
At 31 October 2025 | 16,105 | 16,105
Carrying amount
At 31 October 2025 | 10,739 | 10,739
At 31 October 2024 | 8,839 | 8,839

7 | Other financial assets (current and non-current)

| 2025 £ | 2024 £
Non-current financial assets
Financial assets at fair value through profit and loss | 200,000 | 200,000

8 | Debtors

| Note | 2025 £ | 2024 £
Trade debtors |  | 28,730 | 29,340
Amounts owed by group undertakings and undertakings in which the company has a participating interest | 12 | 729,455 | 727,257
Prepayments |  | 336 | 336
|  | 758,521 | 756,933

North West Skincare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

9 | Creditors

Creditors: amounts falling due within one year

| 2025 £ | 2024 £
Due within one year |  |
Trade creditors | 5,555 | 3,696
Taxation and social security | 67,847 | 58,631
Accruals and deferred income | 3,420 | 3,420
Other creditors | 115,680 | 85,932
| 192,502 | 151,679

10 | Share capital

Allotted, called up and fully paid shares

| 2025 | 2024
| No. | £ | No. | £
Ordinary A of £1 each | 100 | 100 | 100 | 100
Ordinary B of £1 each | 100 | 100 | 100 | 100
| 200 | 200 | 200 | 200

11 | Dividends

Interim dividends paid

|  | 2025 £ |  | 2024 £
Interim dividend of £5.00 (2024 - £50.00) per each Ordinary A |  | 500 |  | 5,000
Interim dividend of £388.50 (2024 - £424.94) per each Ordinary B |  | 38,850 |  | 42,494
|  | 39,350 |  | 47,494

North West Skincare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2025

12 | Related party transactions

Directors' remuneration

The directors' remuneration for the year was as follows:

| 2025 £ | 2024 £
Remuneration | 13,556 | 12,774
Contributions paid to money purchase schemes | - | 60,000
| 13,556 | 72,774

Summary of transactions with all entities with joint control or significant interest

North West Capital Ventures Ltd
Connected Entity Loan
During the year, the company issued loans amounting to £2,198 (2024: £1,987) to the connected entity which is controlled by virtue of Dr M T Atherton & Dr J T Lear shareholding and directorship in the same.
At the balance sheet date connected entity owed North West Skincare Ltd £729,455 (2024: £727,257) in the form of an interest free intercompany loan with no specific repayment terms.

13 | Parent and ultimate parent undertaking

The ultimate controlling party is the directors.

North West Skincare Ltd

Detailed Profit and Loss Account for the Year Ended 31 October 2025

| 2025 £ | 2024 £
Turnover (analysed below) | 383,198 | 406,331
Gross profit (%) | 100% | 100%
Administrative expenses |  |
Employment costs (analysed below) | (27,752) | (86,970)
Establishment costs (analysed below) | (13,154) | (13,073)
General administrative expenses (analysed below) | (78,420) | (76,750)
Finance charges (analysed below) | (377) | (458)
Depreciation costs (analysed below) | (3,725) | (3,695)
| (123,428) | (180,946)
Operating profit | 259,770 | 225,385
Other interest receivable and similar income (analysed below) | 1,547 | 2,777
Profit before tax | 261,317 | 228,162

North West Skincare Ltd

Detailed Profit and Loss Account for the Year Ended 31 October 2025

| 2025 £ | 2024 £

Turnover |  |
Patient income | 367,481 | 392,469
Non-patient income | 15,717 | 13,862
| 383,198 | 406,331

Employment costs |  |
Wages and salaries (excluding directors) | (14,196) | (14,196)
Directors remuneration | (9,098) | (9,096)
Directors pensions (Defined contribution) | - | (60,000)
Directors health insurance | (4,458) | (3,678)
| (27,752) | (86,970)

Establishment costs |  |
Rent | (13,154) | (13,073)

General administrative expenses |  |
Telephone and fax | (992) | (676)
Computer software and maintenance costs | (398) | (204)
Printing, postage and stationery | (80) | (143)
Trade subscriptions | (2,331) | (632)
Admin assistance | (37,990) | (36,099)
Charitable donations | - | (151)
Sundry expenses | (331) | (701)
Motor expenses | (5,400) | (5,932)
Motor insurance | (505) | (429)
Travel and subsistence | (14,766) | (11,348)
Customer entertaining (disallowable for tax) | (6,317) | (10,055)
Accountancy fees | (3,720) | (4,397)
Professional indemnity insurance | (4,561) | (4,479)
Legal and professional fees | (354) | (354)
Bad debts written off | (675) | (1,150)
| (78,420) | (76,750)

Finance charges |  |
Bank charges | (377) | (458)

Depreciation costs |  |
Depreciation of fixtures and fittings (owned) | (3,725) | -
Depreciation of office equipment (owned) | - | (3,695)
| (3,725) | (3,695)

North West Skincare Ltd

Detailed Profit and Loss Account for the Year Ended 31 October 2025

| 2025 £ | 2024 £

Other interest receivable and similar income |  |
Bank interest receivable | 1,476 | 2,267
Other interest receivable | 71 | 510
| 1,547 | 2,777